Company Filing History:
Years Active: 2000
Title: **Bernard M. Kiernan: Innovator in Pharmaceutical Technologies**
Introduction
Bernard M. Kiernan, based in Ashburn, Virginia, is a notable inventor recognized for his contributions to pharmaceutical technologies. With two patents to his name, Kiernan has made significant strides in the development of innovative dosage forms and processing techniques.
Latest Patents
Kiernan’s latest patents showcase his expertise in creating advanced pharmaceutical compositions. His first patent focuses on "Fatty Ester Combinations." This invention pertains to the thermoforming of compositions that contain active agents, specifically through the use of certain fatty esters in combination, enhancing the efficacy of the formulations. The second patent, titled "Immediate Release Dosage Forms Containing Microspheres," deals with microspheres tailored for pharmaceutical applications. These microspheres, which include both active and solubilizing agents, are meticulously processed using liquiflash techniques, promising better performance in drug delivery.
Career Highlights
Throughout his career at Fuisz Technologies Ltd., Bernard M. Kiernan has exemplified dedication to enhancing pharmaceutical formulations. His innovative approaches to exploring new methods of drug delivery have not only benefited his company but also contributed to the broader field of pharmaceutical sciences.
Collaborations
Kiernan collaborates with esteemed professionals such as Steven E. Frisbee and Joseph Cascone, whose combined expertise fosters a creative environment that promotes groundbreaking innovations in the pharmaceutical landscape. These collaborations have led to the successful development of key inventions that push the boundaries of existing technologies.
Conclusion
In conclusion, Bernard M. Kiernan's work exemplifies the spirit of innovation within the pharmaceutical industry. His patents not only reflect his ingenuity but also highlight the potential impact of his inventions on improving drug delivery systems. As he continues to develop new technologies at Fuisz Technologies Ltd., Kiernan remains a pivotal figure in the realm of pharmaceutical innovations.